WAG
IDXX icon

Wallace Advisory Group’s Idexx Laboratories IDXX Stock Holding History

Wallace Advisory Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$261K Sell
465
-176
-27% -$113K 0.28% 100
2025
Q4 		$434K Sell
641
-558
-47% -$380K 0.46% 54
2025
Q3 		$643K Buy
+1,199
New +$728K 0.52% 48
2025
Q1 		– Sell
-474
Closed -$239K – 194
2024
Q4 		$239K Sell
474
-5
-1% -$2.19K 0.17% 156
2024
Q3 		$233K Hold
479
– – 0.17% 156
2024
Q2 		$233K Buy
+479
New +$240K 0.17% 156

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wallace Advisory Group's IDXX Position: Q1 2026 in Review

Wallace Advisory Group reduced its Idexx Laboratories (IDXX) stake by 27% in Q1 2026, selling an estimated $113K and leaving 465 shares worth $261K. The position accounts for 0.28% of the portfolio, ranked #100.

Wallace Advisory Group first reported a position in IDXX in Q2 2024 and has held it in 6 quarters since. The position peaked at $643K in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Wallace Advisory Group held 465 shares of Idexx Laboratories worth $261K as of Q1 2026.
  • Wallace Advisory Group sold 176 Idexx Laboratories shares in Q1 2026, an estimated $113K.
  • Idexx Laboratories made up 0.28% of Wallace Advisory Group's portfolio in Q1 2026, its #100 holding.
  • Wallace Advisory Group first reported a position in Idexx Laboratories in Q2 2024 and has held it in 6 quarters since.
  • Wallace Advisory Group's Idexx Laboratories position peaked at $643K in Q3 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Wallace Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.